[BAX] Baxter International Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 44.21 Change: 0.05 (0.11%)
Ext. hours: Change: 0 (0%)

chart BAX

Refresh chart

Strongest Trends Summary For BAX

BAX is in the medium-term up 15% above S&P in 1 year. In the long-term up 40% in 2 years and up 153% in 7 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Its BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The company?s Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics; products and services related to pharmacy compounding, drug formulation, and packaging technologies; and technologies and therapies for peritoneal dialysis, in-center and home hemodialysis, and continuous renal replacement

Fundamental Ratios
Shares Outstanding EPS1.04 EPS Growth - 4 Quarters-41.96% EPS Growth - Q/Q-77.94%
EPS Growth - Y/Y41.76% Sales Growth - 4 Quarters -13.81% Sales Growth - Q/Q-15.83% P/E55.7
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA9.54% ROE32.67% ROI12.64%
Current Ratio1.6 Quick Ratio1.03 Long Term Debt/Equity2.1 Debt Ratio0.84
Gross Margin48.63% Operating Margin15.2% Net Profit Margin14.29% Dividend Payout Ratio-46.86%
Dividend Yield
Fundamental Data
Cash From Financing Activities384 M Cash From Investing Activities-770 M Cash From Operating Activities96 M Gross Profit1.92 B
Net Profit332 M Operating Profit435 M Total Assets24.86 B Total Current Assets9.73 B
Total Current Liabilities6.07 B Total Debt10.01 B Total Liabilities17.6 B Total Revenue3.89 B
Technical Data
High 52 week85.94 Low 52 week60.9 Last close85.75 Last change0.27%
RSI61.7 Average true range1.91 Beta0.59 Volume1.84 M
Simple moving average 20 days2.35% Simple moving average 50 days5.51% Simple moving average 200 days16.44%
Performance Data
Performance Week1.5% Performance Month4.17% Performance Quart13.53% Performance Half20.89%
Performance Year19.58% Performance Year-to-date31.32% Volatility daily1.28% Volatility weekly2.86%
Volatility monthly5.85% Volatility yearly20.28% Relative Volume171.45% Average Volume2.28 M
New High New Low

News

2020-05-27 18:11:10 | Al Gore Sells Credicorp and Adds 3 New Holdings

2020-05-27 12:16:33 | Point72 Asset Management Buys Micron Technology, Baxter

2020-05-27 06:22:10 | Baxter Receives CE Marking for Evo IQ Syringe Infusion System

2020-05-20 15:06:44 | Mexico orders probe into alleged graft linked to ex-president

2020-05-20 10:22:07 | Baxter International Inc. -- Moody's announces completion of a periodic review of ratings of Baxter International Inc.

2020-05-20 09:00:00 | Baxter Receives CE Marking and Australian Regulatory Approval for Evo IQ Syringe Infusion System, Building on Smart Pump Platform

2020-05-18 19:26:32 | Daniel Loeb Exits Campbell Soup and Trims Baxter in the 1st Quarter

2020-05-18 15:49:20 | Third Point Exits Campbell Soup, Trims Baxter International

2020-05-06 09:00:00 | Baxter Announces Results of Clinical Trial on Benefits of Dynamic Fluid Management in Septic Shock Patients

2020-05-05 08:54:00 | Baxter boosts dividend by 11%, but still yields less than health care ETF

2020-05-05 08:45:00 | Baxter Increases Dividend and Declares Quarterly Dividend

2020-05-04 15:49:43 | Were Hedge Funds Right About Baxter International BAX?

2020-04-30 21:00:41 | Baxter International Inc BAX Q1 2020 Earnings Call Transcript

2020-04-30 18:16:05 | Edited Transcript of BAX earnings conference call or presentation 30-Apr-20 12:30pm GMT

2020-04-30 12:00:00 | Baxter Beats Q1 Estimates as COVID-19 Boosts Sales

2020-04-30 09:24:01 | Baxter BAX Q1 Earnings and Revenues Surpass Estimates

2020-04-30 07:15:00 | Baxter Reports First-Quarter 2020 Results

2020-04-29 11:09:03 | Medical Products Stock Earnings on Apr 30: BAX, IDXX & More

2020-04-27 16:15:00 | Baxter to Present at the UBS Virtual Global Healthcare Conference

2020-04-27 09:54:01 | Baxter BAX to Report Q1 Earnings: What's in the Offing?

2020-04-24 09:59:01 | ABIOMED ABMD to Report Q4 Earnings: What's in the Cards?

2020-04-23 16:15:00 | Baxter to Present at the Virtual BofA Securities 2020 Health Care Conference

2020-04-23 14:30:00 | Baxter Obtains U.S. FDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment

2020-04-20 13:40:44 | Medtech Climbs While JPMorgan Warns Fear May Slow Recovery

2020-04-17 16:15:00 | Baxter to Host First-Quarter 2020 Financial Results Conference Call for Investors

2020-04-17 12:10:04 | Why Baxter BAX is Poised to Beat Earnings Estimates Again

2020-04-16 12:50:00 | Medical Product Maker Baxter Near Buy Zone, Hiring Employees; Earnings Due

2020-04-16 11:30:03 | Baxter BAX Up 2.7% Since Last Earnings Report: Can It Continue?

2020-04-15 17:56:21 | Baxter to hire 2,000 employees as demand for medical products surge

2020-04-15 16:49:00 | Baxter Provides Update on COVID-19 Response Efforts

2020-04-04 15:12:49 | Top Insider Buys Highlight for the Week of April 3

2020-03-31 16:30:00 | Baxter To Host Its Annual Meeting Of Stockholders In Virtual Format

2020-03-24 15:16:13 | Baxter International Inc. -- Moody's assigns Baa1 rating to Baxter's senior unsecured notes

2020-03-19 14:04:23 | Edwards Lifesciences: A Leader in an Economically Attractive and Rapidly Growing Niche

2020-03-19 10:35:02 | Baxter BAX Looks Good: Stock Adds 5.1% in Session

2020-03-19 09:50:01 | Here's Why You Should Hold Onto Baxter BAX Stock for Now

2020-03-18 17:57:27 | 3 Gurus Outperforming the US Market as Stocks Tumble

2020-03-17 19:21:12 | Edited Transcript of BAX earnings conference call or presentation 17-Mar-20 12:30pm GMT

2020-03-17 09:53:01 | Baxter BAX Q4 Earnings Beat Estimates, Revenues In Line

2020-03-17 07:25:00 | Baxter Reports Fourth-Quarter and Full-Year 2019 Results, Completes Financial Restatement Process

2020-03-17 06:30:00 | Baxter International, Inc. to Host Earnings Call

2020-03-11 16:48:00 | Baxter to Host Fourth-quarter 2019 Financial Results Conference Call for Investors

2020-03-11 12:41:24 | Hedge Funds Are Buying Baxter International Inc. BAX

2020-03-11 09:35:01 | Why Earnings Season Could Be Great for Baxter BAX

2020-03-03 15:40:00 | Coronavirus update: 92,817 cases, 3,159 deaths

2020-02-27 11:55:30 | Utah Medical Products: A Micro-Cap Case of Superior Capital Allocation

2020-02-26 08:38:01 | Why Earnings Season Could Be Great for Baxter BAX

2020-02-24 06:41:39 | Why You Might Be Interested In Baxter International Inc. NYSE:BAX For Its Upcoming Dividend

2020-02-20 08:05:01 | Baxter's Latest Acquisition to Boost Advanced Surgery Arm

2020-02-19 16:15:00 | Baxter to Present at the Raymond James 41st Annual Institutional Investors Conference